Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
November 15, 2018
Sierra Oncology Reports Preclinical Efficacy for Chk1 inhibitor SRA737 in Treatment Refractory Ovarian Cancer Models at the EORTC-NCI-AACR Symposium
VANCOUVER, Nov. 15, 2018 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing targeted therapeutics for the treatment of patients ...
November 15, 2018
Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag
SAN DIEGO and RESEARCH TRIANGLE PARK, N.C., Nov. 15, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) and United Therapeutics Corporation (UTHR) today announced that the companies ...
November 15, 2018
Heat Biologics Reports Third Quarter 2018 Results and Provides Corporate Update
DURHAM,NC / ACCESSWIRE / November 15, 2018 / Heat Biologics, Inc. (HTBX), a biopharmaceutical company developing therapies designed to activate a patient's immune system against ...
November 15, 2018
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results
REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of ...
November 15, 2018
Genocea To Host a Key Opinion Leader Event November 26th on Latest Advances in Personalized Cancer Immunotherapies
CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc.(GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, announced today that it will host a ...
November 15, 2018
Novus Therapeutics to Present at the 2018 Piper Jaffray Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), ...
November 15, 2018
Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018
REDWOOD CITY, Calif., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare ...
November 15, 2018
Vaccinex, Inc. Gives Podium Presentation and Poster at the Society for Immunotherapy of Cancer Annual Meeting
ROCHESTER, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat ...
November 15, 2018
TRACON Pharmaceuticals Presents New Circulating Tumor Cell Data from Ongoing Pivotal Phase 3 TAPPAS Trial of TRC105 and Votrient® in Patients with Angiosarcoma
SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
November 14, 2018
iCAD Reports Third Quarter 2018 Financial Results
NASHUA, N.H., Nov. 13, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), a global medical technology company providing innovative cancer detection and therapy solutions, today reported ...
November 14, 2018
OncoCyte Reports Third Quarter 2018 Financial Results and Progress in DetermaVu™ Development
ALAMEDA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) --  OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung ...
November 14, 2018
Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a company focused on the development of novel immunotherapies based on proprietary ...
November 14, 2018
Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and ...
November 14, 2018
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update
GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and nine months ...
November 14, 2018
Basilea presents preclinical data on its anticancer drug candidate BAL101553 at EORTC-NCI-AACR symposium
Basel, Switzerland, November 14, 2018 - Basilea Pharmaceutica Ltd. (SIX:BSLN) announced today that it is presenting new preclinical data on its clinical stage anticancer drug ...
November 14, 2018
Genkyotex to Present Corporate Overview at Stifel 2018 Healthcare Conference
ARCHAMPS, France--(BUSINESS WIRE)--Regulatory News: Genkyotex (GKTX.PA) (GKTX.PA)(GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, today announced that ...
November 14, 2018
DelMar Pharmaceuticals Announces First Quarter Fiscal Year 2019 Financial Results
VANCOUVER, British Columbia and MENLO PARK, Calif., Nov. 14, 2018 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the ...
November 14, 2018
Athenex, Inc. Announces Third Quarter 2018 Financial Results and Provides Corporate Update
BUFFALO, N.Y., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
November 14, 2018
ArQule to Present at the 30th Annual Piper Jaffray Healthcare Conference on November 28, 2018
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Marc Schegerin, Senior Vice President, Head of Strategy, Finance, and Communication ...
November 14, 2018
RedHill Biopharma Announces Presentation on YELIVA® (opaganib) for Multiple Myeloma at EORTC-NCI-AACR Symposium
TEL-AVIV, Israel and RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty ...
Page 15 of 127